ALBUMIN - ANVISA Registration 10287411510
Access comprehensive regulatory information for ALBUMIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411510 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10287411510
25351034554202011
30280358000186
Company Information
Dates and Status
Jul 13, 2020
VIGENTE
09/18/2025 19:00:01
ALBUMIN
ALB2 (Albumin Gen.2)_cobas c
ROCHE DIAGNOSTICS GMBH
10287411384
Jun 10, 2019
ALBUMIN
ALBP (Albumin BCP)_cobas c
ROCHE DIAGNOSTICS GMBH
10287411464
Jan 13, 2020
ALBUMIN
TINA - QUANT (a) ALBUMINA GEN 2
ROCHE DIAGNOSTICS - GMBH
10287410429
Apr 05, 2005
ALBUMIN
Atellica CH Albumina (Alb)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
10345162132
Nov 27, 2017
ALBUMIN
ALB PLUS
ROCHE DIAGNOSTICS
10287410167
Dec 24, 2003
ALBUMINA
Albumina
DIAGAM S.A.
81546350086
Sep 01, 2025
ALBUMINA
Microalbumina
DIAGAM S.A.
81546350087
Sep 01, 2025
ALBUMINA
Família Atellica CH Albumina na Urina (UAlb)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
10345162534
May 05, 2025
ALBUMINA
MICROALBUMINÚRIA EQUIP
QUIBASA QUÍMICA BÁSICA LTDA
10269360462
Apr 28, 2025
ALBUMINA
Família Microalbumina
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390290
Mar 05, 2025